Our analyses also indicate that basal profiling of mitochondria (mtDNA content, expression of OXPHOS proteins, respiration) does not correlate with the sensitivity to RSK/PLK1 inhibition in six melanoma cell lines. The gene discussed is RPS6KA1; the disease is melanoma.